UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000017694
Receipt number R000020429
Scientific Title Efficacy of neoadjuvant chemoradiotherapy with Metformin for locally advanced pancreatic cancer
Date of disclosure of the study information 2015/05/28
Last modified on 2022/12/12 17:47:39

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Efficacy of neoadjuvant chemoradiotherapy with Metformin for locally advanced pancreatic cancer

Acronym

PK-NACRT-Gmet

Scientific Title

Efficacy of neoadjuvant chemoradiotherapy with Metformin for locally advanced pancreatic cancer

Scientific Title:Acronym

PK-NACRT-Gmet

Region

Japan


Condition

Condition

pancreatic cancer

Classification by specialty

Hepato-biliary-pancreatic medicine Hepato-biliary-pancreatic surgery Radiology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the anticancer effect of neoadjuvant chemoradiotherapy using gemcitabine with metformin for locally advanced pancreatic cancer.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

the ratio of histological remnant cancer cells

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Historical

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine Other

Interventions/Control_1

Duration: 3 months
Dose
Neoadjuvant chemoradiation: Gemcitabine(150mg/m2/w)+RT(50.4G/28f)
Metformin: from 5days before starting neoadjuvant chemoradiation until surgery.(1500mg/3x)

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >=

Gender

Male and Female

Key inclusion criteria

1) Certification of pancreatic cancer (histological confirmation is desired).
2) Beyond borderline resectable pancreatic cancer (NCCN guideline 2013 ver.1).
3) No prior anti-tumor therapy for pancreatic cancer.
4) Patient age: over 20 years old, 80 years old or less.
5) Performance status (ECOG) is 0 or 1.
6) Essential organ function is preserved.
WBC counts: over 3000/mm3
Neutrophil counts: over 2000/mm3
Platelets counts: over10^4/mm3
Hb: over 9 g/dl
TBil: below 3.0 mg/dl
AST/ALT: 5 times less than the upper limit of normal
Serum creatinine: below 1.3mg/dl (male) 1.2mg/dl (female)
7) Patients with type 2 diabetes
8) Written consent has been obtained from the patient himself.

Key exclusion criteria

1) Pulmonary fibrosis or interstitial pneumonia
2) severe infectious disease
3) Patients with uncontrolled heart failure , angina, arrhythmias, and myocardial infarction within 6 months after the onset.
4) uncontrolled diabetes
5) Patients with active infection
6) Patients with pregnant women, the possibility or intention of lactating and pregnant.
7)severe drug allergy
8)peptic ulcer and bleeding
9)obvious neurological disorder or mental disorder
10)active double cancer
11)Patients who are already administered metformin
12)other severe complications
13)The patients who are judged inadequate to the present study by Principal investigator or researcher.

Target sample size

40


Research contact person

Name of lead principal investigator

1st name Akinobu
Middle name
Last name Taketomi

Organization

Hokkaido University Graduate School of Medicine

Division name

Gastroenterological Surgery 1

Zip code

060-8638

Address

N15, W-7, Kita-ku Sapporo Japan

TEL

011-706-5927

Email

taketomi@med.hokudai.ac.jp


Public contact

Name of contact person

1st name Tatsuhiko
Middle name
Last name Kakisaka

Organization

Hokkaido University Hospital

Division name

Gastroenterological Surgery 1

Zip code

060-8638

Address

N15, W-7, Kita-ku Sapporo Japan

TEL

011-706-5927

Homepage URL


Email

kakisaka@pop.med.hokudai.ac.jp


Sponsor or person

Institute

Hokkaido University Graduate School of Medicine Gastroenterological Surgery 1

Institute

Department

Personal name



Funding Source

Organization

Hokkaido University Graduate School of Medicine Gastroenterological Surgery 1

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Hokkaido University Hospital Division of Clinical Research Administration

Address

Kita 14, Nishi 5, Kita-ku, Sapporo, Hokkaido, 060-8648 Japan

Tel

011-701-7636

Email

crjimu@huhp.hokudai.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

北海道大学病院(北海道)


Other administrative information

Date of disclosure of the study information

2015 Year 05 Month 28 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2015 Year 05 Month 25 Day

Date of IRB

2015 Year 05 Month 14 Day

Anticipated trial start date

2015 Year 06 Month 18 Day

Last follow-up date

2025 Year 12 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2015 Year 05 Month 27 Day

Last modified on

2022 Year 12 Month 12 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000020429


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name